Dose intensive chemotherapy for children less than ten years of age newly-diagnosed with malignant brain tumors: a pilot study of two alternative intensive induction chemotherapy regimens, followed by consolidation with myeloablative chemotherapy (thiotepa and carboplatin, with or without etoposide) and autologous stem cell rescue [HEAD START III]
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Carboplatin; Cisplatin; Cyclophosphamide; Etoposide; Methotrexate; Temozolomide; Thiotepa; Vincristine
- Indications Brain cancer
- Focus Therapeutic Use
- Acronyms HEAD-START-III
- 18 Dec 2013 Biomarkers information updated
- 20 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Oct 2008 Planned end date 1 Dec 2010 added as reported by CT.gov